Videos (0)

This item doesn’t have any videos yet

Add New Video
EBVM

Medical | Reference

iOS

A collaborative, dynamic, evidence-based, pan-species veterinary formulary

Developed by vets, for vets. EBVM VetFormulary allows everyone from clinicians, pharmacologists to animal carers and pet owners to find accurate and safe information regarding medicines in all species.

Authors:
Stuart McArthur MRCVS
Nick Jackson MRCVS

Consultants:
Steve Smith, BVetMed (Hons.), CertZooMed, DipECZM (Avian), MRCVS
Stephen J. Divers BVetMed, DZooMed, DECZM(Herp), DECZM(ZHM), DACZM, FRCVS

Creating a truly pan species, evidence based formulary is no mean feat, this requires the effort of a great many dedicated vets and scientists. That is why we value our collaborative community and invite and welcome feedback to help make sure all the information is as up to date in our rapidly developing field of veterinary medicines.

The app makes use of all the available information to inform safe, effective use of medicines in any species. This includes pharmacology data for dogs, cats, rabbits, reptiles, birds, small mammals and other exotic pet species.

The availability of this information facilitates safe medicines supply in line with UK, EU and USA dispensing legislation. Any special considerations for dispensing and for humans handling medications is clearly defined to ensure the safest use of medicines even when unauthorised use is required.

Our evidence grading system provides a clear, instant and transparent view of the quality of data supporting the doses suggested. References from PubMed abstracts and other available sources are reviewed and scores generated using a clear evidence matrix to generate reliable and reassuring scores.

Evidence grading is clear and ranges across five classes
0 = Negative Evidence
1 = Very-Low-Quality/Anecdotal Evidence
2 = Low-Quality Evidence
3 = Moderate-Quality Evidence
4 = High-Quality Evidence

Simple Icon-based navigation encourages rapid searching by species, therapeutic class, or by named drug. Medication information can be located quickly and accurately down to species level, via clean search mechanisms.

User feedback routes help to ensure data is accurate and appropriate. Users are provided with direct feedback routes from within the app allowing them to comment upon drug data. This means the service is able to evolve as a collective EBVM collaboration via users and invited consultants.

The VetFormulary app allows direct printing of client information sheets when unauthorized medications are supplied. This encourages and facilitates safe medicine supply to the public whenever veterinary medicines are dispensed.

VetFormulary is dedicated to the establishment of an independent collaboration network, through the development and maintenance of shared principles, taxonomy, tools, and resources, suited to both exotic animal and mainstream veterinary disciplines.

Today, VetFormulary offers pan species evidential reviews for drug doses.

==

To be able to access the Animal database and latest Drug information, and all of the functions within this app you will need an ongoing subscription service.

New Accounts will have a free trial period to test VetFormulary, after which you MUST subscribe to continue to have access to the data within the app.

Subscriptions are available in the following durations:
1 month
3 months
6 months
12 months

Payments are charged to your iTunes account and will automatically renew after the subscription period, unless auto-renew is turned off at least 24-hours before the end of the current period. Subscriptions may be cancelled in your device Account Settings at any time. Any unused portion of a free trial will be forfeit if a subscription is purchased.

http://www.vetformulary.com/content/our-policies



Published by Stuart McArthur
Developed by Stuart McArthur
Certificate 4+
Languages English
Compatibility iPad, iPhone, iPod

Images And Data Courtesy Of: Stuart McArthur.
This content (including text, images, videos and other media) is published and used in accordance with Fair Use.